124 related articles for article (PubMed ID: 14716187)
1. Effect of tibolone and its metabolites on vascular endothelial growth factor isoforms 121 and 165 and thrombospondin-1 mRNA in Ishikawa cells.
Mirkin S; Mahony MC; Archer DF
Menopause; 2004; 11(1):82-8. PubMed ID: 14716187
[TBL] [Abstract][Full Text] [Related]
2. Effects of tibolone and its metabolites on Angiopoietin-1, Tie-2 and tumor necrosis factor-alpha mRNA in Ishikawa cells. Implication for tibolone's effects on the endometrium.
Mirkin S; Archer DF
Maturitas; 2007 Aug; 57(4):338-46. PubMed ID: 17478063
[TBL] [Abstract][Full Text] [Related]
3. Effect of 17 beta-estradiol, progesterone, synthetic progestins, tibolone, and tibolone metabolites on vascular endothelial growth factor mRNA in breast cancer cells.
Mirkin S; Wong BC; Archer DF
Fertil Steril; 2005 Aug; 84(2):485-91. PubMed ID: 16084894
[TBL] [Abstract][Full Text] [Related]
4. Effects of mifepristone on vascular endothelial growth factor and thrombospondin-1 mRNA in Ishikawa cells: implication for the endometrial effects of mifepristone.
Mirkin S; Archer DF
Contraception; 2004 Oct; 70(4):327-33. PubMed ID: 15451338
[TBL] [Abstract][Full Text] [Related]
5. Effects of 17beta-estradiol, progesterone, synthetic progestins, tibolone, and raloxifene on vascular endothelial growth factor and Thrombospondin-1 messenger RNA in breast cancer cells.
Mirkin S; Wong BC; Archer DF
Int J Gynecol Cancer; 2006; 16 Suppl 2():560-3. PubMed ID: 17010073
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of oestrone sulphatase activity by tibolone and its metabolites.
Purohit A; Malini B; Hooymans C; Newman SP
Horm Metab Res; 2002 Jan; 34(1):1-6. PubMed ID: 11832993
[TBL] [Abstract][Full Text] [Related]
7. Bioequivalence studies of tibolone in premenopausal women and effects on expression of the tibolone-metabolizing enzyme AKR1C (aldo-keto reductase) family caused by estradiol.
Kang KW; Kim YG
J Clin Pharmacol; 2008 Dec; 48(12):1430-7. PubMed ID: 18832293
[TBL] [Abstract][Full Text] [Related]
8. Regulation of SULT1E1 expression in Ishikawa adenocarcinoma cells by tibolone.
Falany JL; Falany CN
Steroids; 2006 Oct; 71(10):880-5. PubMed ID: 16857224
[TBL] [Abstract][Full Text] [Related]
9. Effect of raloxifene, 17beta-estradiol, and progesterone on mRNA for vascular endothelial growth factor isoforms 121 and 165 and thrombospondin-1 in Ishikawa cells.
Navarro FJ; Mirkin S; Archer DF
Fertil Steril; 2003 Jun; 79(6):1409-15. PubMed ID: 12798890
[TBL] [Abstract][Full Text] [Related]
10. Agonist activity of the 3-hydroxy metabolites of tibolone through the oestrogen receptor in the mouse N20.1 oligodendrocyte cell line and normal human astrocytes.
Guzmán CB; Zhao C; Deighton-Collins S; Kleerekoper M; Benjamins JA; Skafar DF
J Neuroendocrinol; 2007 Dec; 19(12):958-65. PubMed ID: 18001325
[TBL] [Abstract][Full Text] [Related]
11. Selective tissue distribution of tibolone metabolites in mature ovariectomized female cynomolgus monkeys after multiple doses of tibolone.
Verheul HA; van Iersel ML; Delbressine LP; Kloosterboer HJ
Drug Metab Dispos; 2007 Jul; 35(7):1105-11. PubMed ID: 17420283
[TBL] [Abstract][Full Text] [Related]
12. Hormone therapy and endometrial angiogenesis.
Mirkin S; Navarro F; Archer DF
Climacteric; 2003 Dec; 6(4):273-7. PubMed ID: 15006248
[TBL] [Abstract][Full Text] [Related]
13. Tibolone is metabolized by the 3alpha/3beta-hydroxysteroid dehydrogenase activities of the four human isozymes of the aldo-keto reductase 1C subfamily: inversion of stereospecificity with a delta5(10)-3-ketosteroid.
Steckelbroeck S; Jin Y; Oyesanmi B; Kloosterboer HJ; Penning TM
Mol Pharmacol; 2004 Dec; 66(6):1702-11. PubMed ID: 15383625
[TBL] [Abstract][Full Text] [Related]
14. Antioxidant effect of the active metabolites of tibolone.
Stark J; Varbiro S; Sipos M; Tulassay Z; Sara L; Adler I; Dinya E; Magyar Z; Szekacs B; Marczell I; Kloosterboer HJ; Racz K; Bekesi G
Gynecol Endocrinol; 2015 Jan; 31(1):31-5. PubMed ID: 25054375
[TBL] [Abstract][Full Text] [Related]
15. Tibolone and its metabolites inhibit invasion of human mammary carcinoma cells in vitro.
Vanhoecke BW; Bracke ME; Kloosterboer HJ; Depypere HT
Maturitas; 2006 Jun; 54(3):229-37. PubMed ID: 16581209
[TBL] [Abstract][Full Text] [Related]
16. Progestagenic effects of tibolone are target gene-specific in human endometrial cells.
Zhang W; Mazella J; Kloosterboer HJ; Tseng L
J Soc Gynecol Investig; 2006 Sep; 13(6):459-65. PubMed ID: 16879988
[TBL] [Abstract][Full Text] [Related]
17. Sulfation of tibolone metabolites by human postmenopausal liver and small intestinal sulfotransferases (SULTs).
Wang M; Ebmeier CC; Olin JR; Anderson RJ
Steroids; 2006 May; 71(5):343-51. PubMed ID: 16360722
[TBL] [Abstract][Full Text] [Related]
18. Effects of tibolone on nuclear receptors in human endometrial cells.
Zhang W; Mazella J; Kloosterboer HJ; Tseng L
Am J Obstet Gynecol; 2006 Jul; 195(1):97-102. PubMed ID: 16813748
[TBL] [Abstract][Full Text] [Related]
19. Tibolone metabolism in human liver is catalyzed by 3alpha/3beta-hydroxysteroid dehydrogenase activities of the four isoforms of the aldo-keto reductase (AKR)1C subfamily.
Steckelbroeck S; Oyesanmi B; Jin Y; Lee SH; Kloosterboer HJ; Penning TM
J Pharmacol Exp Ther; 2006 Mar; 316(3):1300-9. PubMed ID: 16339391
[TBL] [Abstract][Full Text] [Related]
20. Estrogen and selective estrogen receptor modulators regulate vascular endothelial growth factor and soluble vascular endothelial growth factor receptor 1 in human endometrial stromal cells.
Okada H; Tsutsumi A; Imai M; Nakajima T; Yasuda K; Kanzaki H
Fertil Steril; 2010 May; 93(8):2680-6. PubMed ID: 19828145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
